1-11 of 11
Mark Chao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma

Barry Paul, Michaela Liedtke, Jorge Monge, Maria Chaudhry, Robert M. Rifkin, Mitul D. Gandhi, Jack Khouri, Andrew Kin, Tibor Kovacsovics, Moshe Y. Levy, Ann Mohrbacher, William Schmidt, David S. Siegel, Rebecca W. Silbermann, Anna Louise Byrne, Tina Ncube, Michael Murphy, Lin Gu, Nishanthan Rajakumaraswamy, Mark Chao, Saad Z. Usmani
Journal: Blood
Blood (2021) 138 (Supplement 1): 2757.
https://doi.org/10.1182/blood-2021-145903
Published: 2021
Journal Articles

Combined Blockade of CD47-Sirpa Interaction By 5F9 (Magrolimab) and Azacitidine/Venetoclax Therapy Facilitates Macrophage-Mediated Anti-Leukemia Efficacy in AML Pre-Clinical Models

Yannan Jia, Qi Zhang, Connie Weng, Cassandra L Ramage, Yuki Nishida, Mark Chao, Roy Louis Maute, Shelley Herbrich, Weiguo Zhang, Michael Andreeff, Naval Daver, Marina Konopleva
Journal: Blood
Blood (2021) 138 (Supplement 1): 510.
https://doi.org/10.1182/blood-2021-147479
Published: 2021
Journal Articles

A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine in Previously Untreated Patients with TP53 -Mutant Acute Myeloid Leukemia

Naval Daver, Paresh Vyas, Mark Chao, Guan Xing, Camille Renard, Giri Ramsingh, David A. Sallman, Andrew H. Wei
Journal: Blood
Blood (2021) 138 (Supplement 1): 3426.
https://doi.org/10.1182/blood-2021-145208
Published: 2021
Journal Articles

A Phase 2, Open-Label, Multiarm, Multicenter Study to Evaluate Magrolimab Combined with Antileukemia Therapies for First-Line, Relapsed/Refractory, or Maintenance Treatment of Acute Myeloid Leukemia

Paresh Vyas, Naval Daver, Mark Chao, Guan Xing, Camille Renard, Giri Ramsingh, Andrew H. Wei, David A. Sallman
Journal: Blood
Blood (2021) 138 (Supplement 1): 3424.
https://doi.org/10.1182/blood-2021-145584
Published: 2021
Journal Articles

The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results

David A Sallman, MD, Adam S. Asch, MD, Monzr M. Al Malki, MD, Daniel J. Lee, MD, William B. Donnellan, MD, Guido Marcucci, MD, Suman Kambhampati, MD, Naval G. Daver, MD, Guillermo Garcia-Manero, MD, Rami S. Komrokji, MD, Joanna Van Elk, Ming Lin, PhD, Jens-Peter Volkmer, MD, Chris H Takimoto, MD PhD, Mark Chao, MD PhD, Paresh Vyas, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 569.
https://doi.org/10.1182/blood-2019-126271
Published: 2019
Journal Articles

An All Antibody Approach for Conditioning Bone Marrow for Hematopoietic Stem Cell Transplantation with Anti-cKIT and Anti-CD47 in Non-Human Primates

Kristopher D Marjon, PhD, James Y Chen, MD PhD, Jiaqi Duan, MS, Timothy S Choi, BS, Kavitha Sompalli, MS, Dongdong Feng, PhD, Ofelia Mata, Sharline Chen, B.S., Leslie Kean, MD PhD, Mwe Mwe Chao, MD, Mark Chao, MD PhD, Chris H Takimoto, MD PhD, Balaji Agoram, PhD, Cynthia E. Dunbar, MD, Ravi Majeti, MD PhD, Irving L Weissman, MD, Jie Liu, PhD MD, Jens-Peter Volkmer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4428.
https://doi.org/10.1182/blood-2019-131490
Published: 2019
Journal Articles

Translational Study of Cell Surface Proteins in Non-Hodgkin Lymphoma Patients Treated with the First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Rituximab

Roy Louis Maute, PhD, James Y Chen, MD PhD, Kristopher David Marjon, PhD, Jiaqi Duan, MS, Timothy Choi, BA, Mark Chao, MD PhD, Chris H Takimoto, MD PhD, Balaji Agoram, PhD, Jens-Peter Volkmer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5229.
https://doi.org/10.1182/blood-2019-127526
Published: 2019
Journal Articles

Immunomodulation of NK Cells through 4-1BB (CD137) to Improve the Anti-Lymphoma Activity of Rituximab: Antibody-Based Anti-Lymphoma Synergy

Holbrook E Kohrt, MD, Roch Houot, MD/PhD, Matthew J Goldstein, MD, Kipp Weiskopf, MD, Mark Chao, MD, Lieping Chen, MD/PhD, Thomas Tedder, PhD, Ron Levy, MD
Journal: Blood
Blood (2010) 116 (21): 422.
https://doi.org/10.1182/blood.V116.21.422.422
Published: 2010
Journal Articles

Increased Expression of CD47 Is a Constant Marker in Mouse and Human Myeloid Leukemias.

Catriona Jamieson, Sidd Jaiswal, David Traver, Jason Gotlib, Mark Chao, Irving L. Weissman
Journal: Blood
Blood (2005) 106 (11): 3260.
https://doi.org/10.1182/blood.V106.11.3260.3260
Published: 2005
Journal Articles

Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment.

Catriona Jamieson, Mobin Karimi, Remi Creusot, Robert Negrin, Jason Gotlib, Mark Chao, Carol Jones, Armand Keating, C. Garrison Fathman, James Zehnder, Irving L. Weissman
Journal: Blood
Blood (2005) 106 (11): 696.
https://doi.org/10.1182/blood.V106.11.696.696
Published: 2005
Journal Articles

Molecular Progenitor Profiling in Human Myeloproliferative Disorders.

Catriona H.M. Jamieson, MD, PhD, Jason Gotlib, MD MS, Mark Chao, BS, M Rajan Mariappan, MD, Marla LayRaj, Carol Jones, MS, James Zehnder, MD, Jeffrey Durocher, PhD, Stan Lilleberg, MD, Steven Coutre, MD, Irving L. Weissman, MD
Journal: Blood
Blood (2005) 106 (11): 118.
https://doi.org/10.1182/blood.V106.11.118.118
Published: 2005